Dr. Alsayed is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Multiple Myeloma, Paget Disease of the Breast, and Bone Marrow Aspiration.

Dr. Alsayed is board certified in The American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 4 clinical trials. Dr. Alsayed is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in FL

Board Certifications

The American Board Of Internal Medicine - Medical Oncology

Fellowships

Glaxo Smithkline

Oxford

University of Pittsburgh Medical Center - Radiology

Hospital Affiliations

Ascension Sacred Heart Hospital Pensacola

Sacred Heart Hospital

Baptist Hospital

Baldwin Health

Languages Spoken

English

Arabic

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem BCBS

Blue Cross Blue Shield

Blue Shield of California

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Change Healthcare

OTHER MEDICARE
OTHER MEDICARE PART D

Cigna

Florida Blue

Health Care Services Corporation

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Health Options

Humana

HMO
INDEMNITY
POS
PPO

Managed Medicaid

OTHER MANAGED MEDICAID

Medicaid

OTHER MEDICAID
STATE MEDICAID

Oscar

Premera Blue Cross

INSURANCE PLAN
MEDICARE MAPD
OTHER COMMERCIAL
PPO

Simply Healthcare

MANAGED MEDICAID PLAN
MEDICARE MAPD
OTHER MEDICARE PART D

Sunshine Health

TeamCare

OTHER COMMERCIAL

UnitedHealthcare

Walgreens

MEDICARE DISCOUNT CARD
MEDICARE PDP
OTHER MEDICARE

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 15 Less Insurance Carriers -

Locations

Ascension Sacred Heart Cancer Center - Pensacola
1545 Airport Blvd, Ste 2000, Pensacola, FL 32504

Call: 850-416-6933

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

Enrollment Status: Recruiting

Publish Date: September 04, 2026

Intervention Type: Procedure, Biological, Drug, Other

Study Drugs: Obinutuzumab, Venetoclax

Study Phase: Phase 3

A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)

Enrollment Status: Completed

Publish Date: May 18, 2026

Intervention Type: Drug, Other, Biological

Study Drugs: Afatinib Dimaleate, Cetuximab

Study Phase: Phase 2/Phase 3

Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) Alone or in Combination With Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)

Enrollment Status: Completed

Publish Date: July 03, 2025

Intervention Type: Drug, Biological

Study Drugs: Carboplatin, Cisplatin, Etoposide, Nivolumab

Study Phase: Phase 2

A Randomized Phase II/III Trial of Novel Therapeutics Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial

Enrollment Status: Completed

Publish Date: January 16, 2025

Intervention Type: Drug, Biological, Other

Study Drugs: Azacitidine, Cytarabine, Decitabine, Midostaurin, Nivolumab

Study Phase: Phase 2/Phase 3

View 3 Less Clinical Trials

5 Total Publications

Editor's Note: Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 16, 2024

View All 5 Publications

Frequently Asked Questions about Dr. Yazan M. Alsayed

How do I make an appointment with Dr. Yazan M. Alsayed?

You can book an appointment with Dr. Yazan M. Alsayed by calling their office at 850-416-6933. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Yazan M. Alsayed a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yazan M. Alsayed is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Yazan M. Alsayed specialize in?

While Dr. Yazan M. Alsayed is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Yazan M. Alsayed participate in research or clinical trials?

Yes. Dr. Yazan M. Alsayed has published 5 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Yazan M. Alsayed's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Yazan M. Alsayed accept my insurance?

Dr. Yazan M. Alsayed accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 850-416-6933 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alsayed's expertise for a condition

ConditionClose